Legend Biotech Corp Stock Alpha and Beta Analysis
| LEGN Stock | USD 56.61 2.53 4.28% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Legend Biotech Corp. It also helps investors analyze the systematic and unsystematic risks associated with investing in Legend Biotech over a specified time horizon. Remember, high Legend Biotech's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Legend Biotech's market risk premium analysis include:
Beta 0.26 | Alpha 0.29 | Risk 3.39 | Sharpe Ratio 0.12 | Expected Return 0.42 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Legend |
Legend Biotech Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Legend Biotech market risk premium is the additional return an investor will receive from holding Legend Biotech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Legend Biotech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Legend Biotech's performance over market.| α | 0.29 | β | 0.26 |
Legend Biotech expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Legend Biotech's Buy-and-hold return. Our buy-and-hold chart shows how Legend Biotech performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Legend Biotech Market Price Analysis
Market price analysis indicators help investors to evaluate how Legend Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Legend Biotech shares will generate the highest return on investment. By understating and applying Legend Biotech stock market price indicators, traders can identify Legend Biotech position entry and exit signals to maximize returns.
Legend Biotech Return and Market Media
The median price of Legend Biotech for the period between Sun, Apr 28, 2024 and Sat, Jul 27, 2024 is 45.26 with a coefficient of variation of 11.49. The daily time series for the period is distributed with a sample standard deviation of 5.34, arithmetic mean of 46.42, and mean deviation of 3.79. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Legend Biotech to Participate in the Jefferies Global Healthcare Conference | 05/29/2024 |
2 | Legend Biotech Shares Data on the Earliest Use to Date of CARVYKTI in the Treatment of Multiple Myeloma and Important Subgroup Analyses at ASCO and EHA | 06/03/2024 |
3 | Wellington Management Group LLP Acquires 962381 Shares of Legend Biotech Co. - Defense World | 06/20/2024 |
4 | Does Legend Biotech Have a Long Runway for Growth | 06/24/2024 |
5 | Johnson Johnsons Cell Therapy Carvykti Shows Better Survival Rate In Pretreated Blood Cancer Patients | 07/02/2024 |
6 | Legend Biotech to Host Investor Conference Call on Second Quarter 2024 Results | 07/10/2024 |
7 | Legend Biotech Price Target Cut to 67.00 by Analysts at TD Cowen - Defense World | 07/16/2024 |
8 | Legend Biotech expects adj. loss of 102.2M in 1H24 | 07/26/2024 |
About Legend Biotech Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Legend or other stocks. Alpha measures the amount that position in Legend Biotech Corp has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 44.49 | 1.99 | 8.17 | 7.76 | Days Of Inventory On Hand | 2.04 | 57.82 | 43.08 | 45.23 |
Legend Biotech Upcoming Company Events
As portrayed in its financial statements, the presentation of Legend Biotech's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Legend Biotech's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Legend Biotech's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Legend Biotech. Please utilize our Beneish M Score to check the likelihood of Legend Biotech's management manipulating its earnings.
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 16th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Legend Biotech
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Information and Resources on Investing in Legend Stock
When determining whether Legend Biotech Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Legend Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Legend Biotech Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Legend Biotech Corp Stock:Check out Legend Biotech Backtesting, Legend Biotech Valuation, Legend Biotech Correlation, Legend Biotech Hype Analysis, Legend Biotech Volatility, Legend Biotech History and analyze Legend Biotech Performance. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Legend Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.